Anngeen
Latest round
- Series A
Last raised
- Jul 2018
Total raised
- $11M
Investors
- 1
About Anngeen
Based in Beijing, China and established in 2017, Anngeen operates as a biotechnology company that focuses on providing disease detection services for clinical medicine via utilizing gene-sequencing technology.
Who invested in Anngeen
1 investor across 1 round
See all investors in Anngeen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 11, 2018
Amount
$11M
Investors
Questions about Anngeen
Who invested in Anngeen?
Anngeen has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anngeen raised?
Anngeen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anngeen last raise money?
Anngeen's most recent round on record is a Series A, in Jul 2018.
What does Anngeen do?
Based in Beijing, China and established in 2017, Anngeen operates as a biotechnology company that focuses on providing disease detection services for clinical medicine via utilizing gene-sequencing technology.
Where is Anngeen headquartered?
Anngeen is headquartered in Beijing, China.
Which VCs invest in companies like Anngeen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Anngeen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Anngeen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.